---
sidebar_position: 45
---

# æ–‡ç» 45ï¼šThe Next Layer: Augmenting Foundation Models with Structure-Preserving and Attention-Guided Learning for Local Patches to Global Context Awareness in Computational Pathology

**English Title**: The Next Layer: Augmenting Foundation Models with Structure-Preserving and Attention-Guided Learning for Local Patches to Global Context Awareness in Computational Pathology

**ä¸­æ–‡æ¨™é¡Œ**: ä¸‹ä¸€å±¤ï¼šé€šéçµæ§‹ä¿æŒå’Œæ³¨æ„åŠ›å¼•å°å­¸ç¿’å¢å¼·åŸºç¤æ¨¡å‹ï¼Œå¯¦ç¾è¨ˆç®—ç—…ç†å­¸ä¸­å¾å±€éƒ¨åˆ°å…¨å±€ä¸Šä¸‹æ–‡æ„ŸçŸ¥
**PMID**: 40909163
**æœŸåˆŠ**: ArXiv
**è©•åˆ†**: 9
**æ‡‰ç”¨é ˜åŸŸ**: é–€è¨º/ç—…ç†ç§‘
**DOI**: æœªæä¾›

---

## ğŸ“Œ ç¬¬ä¸€å¼µï¼šæ ¸å¿ƒè§€é»å¡

### ä¸»è¦ç™¼ç¾
å¤šå°ºåº¦ç©ºé–“ç·¨ç¢¼å’Œé„°åŸŸæ„ŸçŸ¥æå¤±

### æ–‡ç»æ‘˜è¦ï¼ˆAbstractï¼‰
Foundation models have recently emerged as powerful feature extractors in computational pathology, yet they typically omit mechanisms for leveraging the global spatial structure of tissues and the local contextual relationships among diagnostically relevant regions - key elements for understanding the tumor microenvironment. Multiple instance learning (MIL) remains an essential next step following foundation model, designing a framework to aggregate patch-level features into slide-level predictions. We present EAGLE-Net, a structure-preserving, attention-guided MIL architecture designed to augment prediction and interpretability. EAGLE-Net integrates multi-scale absolute spatial encoding to capture global tissue architecture, a top-K neighborhood-aware loss to focus attention on local microenvironments, and background suppression loss to minimize false positives. We benchmarked EAGLE-Net on large pan-cancer datasets, including three cancer types for classification (10,260 slides) and seven cancer types for survival prediction (4,172 slides), using three distinct histology foundation backbones (REMEDIES, Uni-V1, Uni2-h). Across tasks, EAGLE-Net achieved up to 3% higher classification accuracy and the top concordance indices in 6 of 7 cancer types, producing smooth, biologically coherent attention maps that aligned with expert annotations and highlighted invasive fronts, necrosis, and immune infiltration. These results position EAGLE-Net as a generalizable, interpretable framework that complements foundation models, enabling improved biomarker discovery, prognostic modeling, and clinical decision support.

### ä¸­æ–‡æ‘˜è¦
åŸºç¤æ¨¡å‹æœ€è¿‘ä½œç‚ºè¨ˆç®—ç—…ç†å­¸ä¸­å¼·å¤§çš„ç‰¹å¾µæå–å™¨å‡ºç¾ï¼Œä½†å®ƒå€‘é€šå¸¸çœç•¥äº†åˆ©ç”¨çµ„ç¹”å…¨å±€ç©ºé–“çµæ§‹å’Œè¨ºæ–·ç›¸é—œå€åŸŸä¹‹é–“å±€éƒ¨ä¸Šä¸‹æ–‡é—œä¿‚çš„æ©Ÿåˆ¶â€”â€”é€™æ˜¯ç†è§£è…«ç˜¤å¾®ç’°å¢ƒçš„é—œéµè¦ç´ ã€‚å¤šå¯¦ä¾‹å­¸ç¿’ï¼ˆMILï¼‰ä»ç„¶æ˜¯åŸºç¤æ¨¡å‹ä¹‹å¾Œçš„é‡è¦ä¸‹ä¸€æ­¥ï¼Œè¨­è¨ˆä¸€å€‹æ¡†æ¶å°‡åˆ‡ç‰‡ç´šç‰¹å¾µèšåˆç‚ºå¹»ç‡ˆç‰‡ç´šé æ¸¬ã€‚æˆ‘å€‘æå‡º EAGLE-Netï¼Œä¸€ç¨®ä¿æŒçµæ§‹ã€æ³¨æ„åŠ›å¼•å°çš„ MIL æ¶æ§‹ï¼Œæ—¨åœ¨å¢å¼·é æ¸¬å’Œå¯è§£é‡‹æ€§ã€‚EAGLE-Net æ•´åˆäº†å¤šå°ºåº¦çµ•å°ç©ºé–“ç·¨ç¢¼ä»¥æ•ç²å…¨å±€çµ„ç¹”æ¶æ§‹ï¼Œtop-K é„°åŸŸæ„ŸçŸ¥æå¤±ä»¥å°‡æ³¨æ„åŠ›é›†ä¸­åœ¨å±€éƒ¨å¾®ç’°å¢ƒä¸Šï¼Œä»¥åŠèƒŒæ™¯æŠ‘åˆ¶æå¤±ä»¥æœ€å°åŒ–å‡é™½æ€§ã€‚æˆ‘å€‘åœ¨å¤§å‹æ³›ç™Œç—‡æ•¸æ“šé›†ä¸Šå° EAGLE-Net é€²è¡ŒåŸºæº–æ¸¬è©¦ï¼ŒåŒ…æ‹¬ç”¨æ–¼åˆ†é¡çš„ä¸‰ç¨®ç™Œç—‡é¡å‹ï¼ˆ10,260 å¼µåˆ‡ç‰‡ï¼‰å’Œç”¨æ–¼å­˜æ´»é æ¸¬çš„ä¸ƒç¨®ç™Œç—‡é¡å‹ï¼ˆ4,172 å¼µåˆ‡ç‰‡ï¼‰ï¼Œä½¿ç”¨ä¸‰ç¨®ä¸åŒçš„çµ„ç¹”å­¸åŸºç¤éª¨å¹¹ï¼ˆREMEDIESã€Uni-V1ã€Uni2-hï¼‰ã€‚åœ¨æ‰€æœ‰ä»»å‹™ä¸­ï¼ŒEAGLE-Net å¯¦ç¾äº†é«˜é” 3% çš„åˆ†é¡æº–ç¢ºç‡æå‡ï¼Œä¸¦åœ¨ 7 ç¨®ç™Œç—‡é¡å‹ä¸­çš„ 6 ç¨®ä¸­ç²å¾—æœ€é«˜çš„ä¸€è‡´æ€§æŒ‡æ•¸ï¼Œç”¢ç”Ÿèˆ‡å°ˆå®¶æ¨™è¨»ä¸€è‡´çš„å¹³æ»‘ã€ç”Ÿç‰©å­¸ä¸Šé€£è²«çš„æ³¨æ„åŠ›åœ–ï¼Œä¸¦çªå‡ºä¾µè¥²å‰æ²¿ã€å£æ­»å’Œå…ç–«æµ¸æ½¤ã€‚é€™äº›çµæœä½¿ EAGLE-Net æˆç‚ºä¸€å€‹å¯æ¨å»£ã€å¯è§£é‡‹çš„æ¡†æ¶ï¼Œè£œå……åŸºç¤æ¨¡å‹ï¼Œå¯¦ç¾æ”¹é€²çš„ç”Ÿç‰©æ¨™è¨˜ç™¼ç¾ã€é å¾Œå»ºæ¨¡å’Œè‡¨åºŠæ±ºç­–æ”¯æŒã€‚

### é—œéµæ•¸æ“š
- **ç ”ç©¶é¡å‹**: æœªåˆ†é¡
- **åœ‹å®¶/åœ°å€**: å¾…æŸ¥
- **ç™¼è¡¨å¹´ä»½**: å¾…æŸ¥
- **ROI æ•¸å€¼**: ç„¡æ•¸å€¼

### æ ¸å¿ƒå‰µæ–°é»
æœ¬ç ”ç©¶çš„ä¸»è¦å‰µæ–°åœ¨æ–¼ï¼šå¤šå°ºåº¦ç©ºé–“ç·¨ç¢¼å’Œé„°åŸŸæ„ŸçŸ¥æå¤±

---

## âœï¸ ç¬¬äºŒå¼µï¼šParaphrase å¡

### ç ”ç©¶ç›®çš„èˆ‡æ–¹æ³•
æœ¬ç ”ç©¶èšç„¦æ–¼é–€è¨º/ç—…ç†ç§‘é ˜åŸŸï¼Œæ—¨åœ¨æ¢è¨ AI æŠ€è¡“åœ¨é†«ç™‚å ´æ™¯ä¸­çš„æ‡‰ç”¨ã€‚

### ä¸»è¦è²¢ç»
ç ”ç©¶æå‡ºäº†å¤šå°ºåº¦ç©ºé–“ç·¨ç¢¼å’Œé„°åŸŸæ„ŸçŸ¥æå¤±ï¼Œç‚ºè‡¨åºŠå¯¦è¸æä¾›äº†æ–°çš„è§£æ±ºæ–¹æ¡ˆã€‚

### æŠ€è¡“ç‰¹é»
- æ‡‰ç”¨å ´æ™¯ï¼šé–€è¨º/ç—…ç†ç§‘
- å‰µæ–°ç¨‹åº¦ï¼šè©•åˆ† 9/10
- æœŸåˆŠå½±éŸ¿ï¼šç™¼è¡¨æ–¼ ArXiv

---

## â“ ç¬¬ä¸‰å¼µï¼šå•ç­”å¡

### Q1: é€™é …ç ”ç©¶è§£æ±ºäº†ä»€éº¼å•é¡Œï¼Ÿ
A: æœ¬ç ”ç©¶é‡å°é–€è¨º/ç—…ç†ç§‘é ˜åŸŸçš„æŒ‘æˆ°ï¼Œæå‡ºäº†åŸºæ–¼ AI çš„è§£æ±ºæ–¹æ¡ˆã€‚

### Q2: æ¡ç”¨äº†ä»€éº¼æŠ€è¡“æ–¹æ³•ï¼Ÿ
A: å¤šå°ºåº¦ç©ºé–“ç·¨ç¢¼å’Œé„°åŸŸæ„ŸçŸ¥æå¤±

### Q3: ç ”ç©¶çš„ä¸»è¦æˆæœæ˜¯ä»€éº¼ï¼Ÿ
A: ç ”ç©¶ç²å¾—äº† 9 åˆ†çš„å°ˆå®¶è©•åˆ†ï¼Œè­‰æ˜äº†å…¶åœ¨é–€è¨º/ç—…ç†ç§‘é ˜åŸŸçš„æ‡‰ç”¨åƒ¹å€¼ã€‚

### Q4: æœ‰å“ªäº›å¯¦éš›æ‡‰ç”¨å ´æ™¯ï¼Ÿ
A: ä¸»è¦æ‡‰ç”¨æ–¼é–€è¨º/ç—…ç†ç§‘ï¼Œå¯ç”¨æ–¼æ”¹å–„é†«ç™‚æœå‹™å“è³ªå’Œæ•ˆç‡ã€‚

---

## ğŸ¤” ç¬¬å››å¼µï¼šä¾‹å¤–å¡

### æ½›åœ¨é™åˆ¶
1. **ç ”ç©¶ç¯„åœ**: ç ”ç©¶è©•åˆ†ç‚º 9/10ï¼Œå¯èƒ½å­˜åœ¨æ”¹é€²ç©ºé–“
2. **åœ°å€å·®ç•°**: ç ”ç©¶ä¾†è‡ªå¾…æŸ¥ï¼Œå…¶ä»–åœ°å€é©ç”¨æ€§éœ€é©—è­‰
3. **ROI æ•¸æ“š**: ç„¡æ•¸å€¼ï¼Œç¶“æ¿Ÿæ•ˆç›Šè©•ä¼°å¯èƒ½ä¸å®Œæ•´

### éœ€è¦é€²ä¸€æ­¥æ¢è¨çš„å•é¡Œ
1. è©²æŠ€è¡“åœ¨ä¸åŒè¦æ¨¡é†«é™¢çš„é©ç”¨æ€§å¦‚ä½•ï¼Ÿ
2. é•·æœŸä½¿ç”¨çš„æ•ˆæœå’Œç©©å®šæ€§æ˜¯å¦ç¶“éé©—è­‰ï¼Ÿ
3. èˆ‡ç¾æœ‰ç³»çµ±æ•´åˆæ™‚å¯èƒ½é¢è‡¨å“ªäº›æŒ‘æˆ°ï¼Ÿ

### æ‰¹åˆ¤æ€§æ€è€ƒ
- **æŠ€è¡“æˆç†Ÿåº¦**: éœ€è¦è©•ä¼°å¾ç ”ç©¶åˆ°å¯¦éš›éƒ¨ç½²çš„è·é›¢
- **æˆæœ¬æ•ˆç›Š**: ç„¡æ•¸å€¼ï¼Œéœ€è¦æ›´è©³ç´°çš„ç¶“æ¿Ÿåˆ†æ
- **å€«ç†è€ƒé‡**: AI åœ¨é–€è¨º/ç—…ç†ç§‘æ‡‰ç”¨æ™‚çš„å€«ç†å’Œéš±ç§å•é¡Œ
- **å¯æ¨å»£æ€§**: ç ”ç©¶çµæœåœ¨å…¶ä»–é†«ç™‚å ´æ™¯çš„é©ç”¨æ€§

---

## ğŸ“š åƒè€ƒè³‡è¨Š
- **PMID**: [40909163](https://pubmed.ncbi.nlm.nih.gov/40909163/)
- **DOI**: æœªæä¾›
- **æœŸåˆŠ**: ArXiv
